Rubraxanthone is a main active constituent of kandis ( Roxb), has showed many biological activity including antimicrobial, anti hypercholesterolemic, antiplatelet, antioxidant, cytotoxic, and anti-inflammatory properties. To the best of our knowledge, no reports on the pharmacokinetics (PK) of this rubraxanthone have been published. The PK of rubraxanthone in mice was examined after a single oral dose of 700 mg/kg rubraxanthone suspension in virgin coconut oil. Plasma samples were collected at different time points and further analyzed using validated chromatographic method. Pharmacokinetic parameters were calculated from observed plasma concentration-time profile. The maximum concentration of rubraxanthone in plasma was discovered in 1.5 h. The peak plasma concentration (C) was 4.267 μg/mL, and the area under the curve (AUCt0-t ) was 560.99 μg h/L, with a 6.72-hour terminal half-life (T). The volume of distribution (Vd/F) was 1200.19 mL/kg and 1123.88 mL/h/kg clearance (Cl/F).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941156PMC
http://dx.doi.org/10.1016/j.heliyon.2022.e09104DOI Listing

Publication Analysis

Top Keywords

rubraxanthone mice
8
rubraxanthone
6
single dose
4
dose oral
4
oral pharmacokinetic
4
pharmacokinetic profile
4
profile rubraxanthone
4
mice rubraxanthone
4
rubraxanthone main
4
main active
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!